Sartelli, Massimo
Barie, Philip
Agnoletti, Vanni
Al-Hasan, Majdi N.
Ansaloni, Luca
Biffl, Walter
Buonomo, Luis
Blot, Stijn
Cheadle, William G.
Coimbra, Raul
De Simone, Belinda
Duane, Therese M.
Fugazzola, Paola
Giamarellou, Helen
Hardcastle, Timothy C.
Hecker, Andreas
Inaba, Kenji
Kirkpatrick, Andrew W.
Labricciosa, Francesco M.
Leone, Marc
Martin-Loeches, Ignacio
Maier, Ronald V.
Marwah, Sanjay
Maves, Ryan C.
Mingoli, Andrea
Montravers, Philippe
Ordóñez, Carlos A.
Palmieri, Miriam
Podda, Mauro
Rello, Jordi
Sawyer, Robert G.
Sganga, Gabriele
Tattevin, Pierre
Thapaliya, Dipendra
Tessier, Jeffrey
Tolonen, Matti
Ulrych, Jan
Vallicelli, Carlo
Watkins, Richard R.
Catena, Fausto
Coccolini, Federico
Article History
Received: 8 April 2024
Accepted: 1 June 2024
First Online: 8 June 2024
Declarations
:
: Not applicable.
: Not applicable.
: A.W.K. serves as the PI of the COOL trial, which previously was partially supported by the 3 M/Acelity Corporation until Aug 2022. A.W.K. is also a member of the Canadian Forces Medical Services and has consulted for the 3 m/Acelity Corporation, Zoll Medical, Innovative Trauma Care, and CSL Behring. A.W.K. is the Director of the TeleMentored Ultrasound Supported Medical Interventions (TMUSMI) Research group and serves in the Canadian Forces Medical Services.R.G.S conflicts are on Data Management and Safety Board for Advarra.R.C.M. received research support (paid to Institution) from AiCuris, GeoVax and Biotest. He received honoraria for participation in a scientific advisory board organized by Shionogi.All the other authors declare that they have no competing interests. R.G.S conflicts are on Data Management and Safety Board for Advarra. R.C.M. received research support (paid to Institution) from AiCuris, GeoVax and Biotest. He received honoraria for participation in a scientific advisory board organized by Shionogi. All the other authors declare that they have no competing interests.